Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Grade Glioma”

223 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 223 results

Testing effectiveness (Phase 2)Study completedNCT00782626
What this trial is testing

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Who this might be right for
GliomaLow-grade GliomaAstrocytoma
Dana-Farber Cancer Institute 23
Not applicableStudy completedNCT00137488
What this trial is testing

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

Who this might be right for
Glioma
AHS Cancer Control Alberta 10
Not applicableUnknownNCT05019196
What this trial is testing

FMRI Study of Functional Reorganization in Glioma Patients

Who this might be right for
Glioma
First Affiliated Hospital Xi'an Jiaotong University 100
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Not applicableStudy completedNCT01004523
What this trial is testing

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 135
Testing effectiveness (Phase 2)Looking for participantsNCT05964569
What this trial is testing

Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma

Who this might be right for
Low Grade Glioma
University Hospital Heidelberg 120
Early research (Phase 1)Ended earlyNCT02240758
What this trial is testing

Confocal Laser Endomicroscopy for Brain Tumors

Who this might be right for
Low Grade Glioma (LGG), High Grade Glioma (HGG)
Hospices Civils de Lyon 10
Early research (Phase 1)UnknownNCT00360854
What this trial is testing

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 48
Not applicableEnded earlyNCT01452854
What this trial is testing

Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide

Who this might be right for
Low Grade Glioma
University of California, San Francisco 2
Not applicableUnknownNCT03154801
What this trial is testing

Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors (NEUROSEX)

Who this might be right for
Low Grade Glioma of BrainMultiple SclerosisSexual Dysfunctions
Assistance Publique - Hôpitaux de Paris 54
Not applicableWithdrawnNCT05233215
What this trial is testing

GROW (Glioma Specialists Reaching Out With Support) Support

Who this might be right for
Low-grade GliomaSurvivorshipCare Giving Burden
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00238264
What this trial is testing

Radiation Therapy in Treating Young Patients With Gliomas

Who this might be right for
Brain TumorCentral Nervous System Tumor
Children's Oncology Group 92
Early research (Phase 1)Active Not RecruitingNCT03749187
What this trial is testing

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Who this might be right for
GlioblastomaIDH1 Gene MutationIDH2 Gene Mutation+7 more
University of California, San Francisco 78
Early research (Phase 1)Study completedNCT00363272
What this trial is testing

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03718767
What this trial is testing

Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype

Who this might be right for
GliomaGlioblastomaHigh Grade Glioma+2 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04458272
What this trial is testing

DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma

Who this might be right for
WHO Grade II Glioma
Daiichi Sankyo Co., Ltd. 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07004075
What this trial is testing

FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration

Who this might be right for
Low-grade GliomaPediatric Low-grade GliomaspLGG With BRAF Alteration
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 102
Not applicableEnrolling By InvitationNCT04063514
What this trial is testing

The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain Barrier

Who this might be right for
Low Grade Glioma of Brain
Neurological Associates of West Los Angeles 15
Testing effectiveness (Phase 2)UnknownNCT00281905
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Cancer and Leukaemia Group 50
Testing effectiveness (Phase 2)Ended earlyNCT01116661
What this trial is testing

Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain

Who this might be right for
Glioma
University of California, San Francisco 199
Load More Results